These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33031192)

  • 1. Angiotensin II Administration in Patients With COVID-19 Shock.
    Ofosu-Barko K; Liu Y; Alkhatib Tamimi F; Al Husami W; Ganatra S; Resnic F; Shah SP
    Crit Pathw Cardiol; 2021 Jun; 20(2):100-102. PubMed ID: 33031192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the norepinephrine to angiotensin II conversion ratio in patients with vasodilatory hypotension: A post-hoc analysis of the ARAMIS trial.
    See EJ; Chaba A; Spano S; Maeda A; Clapham C; Liu J; Khasin M; Liskaser G; Eastwood G; Bellomo R
    J Crit Care; 2024 Feb; 79():154453. PubMed ID: 37890357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II for the Treatment of Refractory Shock: A Matched Analysis.
    Smith LM; Mentz GB; Engoren MC
    Crit Care Med; 2023 Dec; 51(12):1674-1684. PubMed ID: 37378469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of Synthetic Human Angiotensin II for Catecholamine-Resistant Vasodilatory Shock in Critically Ill Children: A Single-Center Retrospective Case Series.
    Tezel O; Hutson TK; Gist KM; Chima RS; Goldstein SL; Stanski NL
    Crit Care Explor; 2023 Sep; 5(9):e0978. PubMed ID: 37711646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged Respiratory Failure From COVID-19 With New-Onset Shock.
    Whalen W; Parkhurst CN; Mints G; Rajwani K
    Chest; 2021 Dec; 160(6):e673-e675. PubMed ID: 34872685
    [No Abstract]   [Full Text] [Related]  

  • 6. Feasibility and safety of angiotensin II administration in general ward patients during COVID-19 pandemic: a case series.
    Morselli F; Vitali G; Brioschi E; Di Terlizzi G; Belletti A; Lombardi G; Senarighi G; Neto AS; Zangrillo A; Landoni G
    Crit Care Resusc; 2020 Dec; 22(4):388-390. PubMed ID: 38046869
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial.
    Gharebaghi N; Nejadrahim R; Mousavi SJ; Sadat-Ebrahimi SR; Hajizadeh R
    BMC Infect Dis; 2020 Oct; 20(1):786. PubMed ID: 33087047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Almitrine Infusion in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Acute Respiratory Distress Syndrome: A Single-Center Observational Study.
    Caplan M; Goutay J; Bignon A; Jaillette E; Favory R; Mathieu D; Parmentier-Decrucq E; Poissy J; Duburcq T;
    Crit Care Med; 2021 Feb; 49(2):e191-e198. PubMed ID: 33093279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19.
    Wang Y; Tse G; Li G; Lip GYH; Liu T
    J Am Coll Cardiol; 2020 Oct; 76(17):2041. PubMed ID: 33092742
    [No Abstract]   [Full Text] [Related]  

  • 10. Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study.
    Cariou B; Goronflot T; Rimbert A; Boullu S; Le May C; Moulin P; Pichelin M; Potier L; Smati S; Sultan A; Tramunt B; Wargny M; Gourdy P; Hadjadj S;
    Diabetes Metab; 2021 Mar; 47(2):101202. PubMed ID: 33091555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients' performance: a prospective observational cohort study.
    Sonnweber T; Boehm A; Sahanic S; Pizzini A; Aichner M; Sonnweber B; Kurz K; Koppelstätter S; Haschka D; Petzer V; Hilbe R; Theurl M; Lehner D; Nairz M; Puchner B; Luger A; Schwabl C; Bellmann-Weiler R; Wöll E; Widmann G; Tancevski I; Judith-Löffler-Ragg ; Weiss G
    Respir Res; 2020 Oct; 21(1):276. PubMed ID: 33087116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presenting Characteristics, Treatment Patterns, and Outcomes among Patients with Venous Thromboembolism during Hospitalization for COVID-19.
    Fernández-Capitán C; Barba R; Díaz-Pedroche MDC; Sigüenza P; Demelo-Rodriguez P; Siniscalchi C; Pedrajas JM; Farfán-Sedano AI; Olivera PE; Gómez-Cuervo C; Llamas P; Villares P; Sanchez O; López-Reyes R; Catella J; Bikdeli B; Weinberg I; Tafur AJ; Jiménez D; Monreal M
    Semin Thromb Hemost; 2021 Jun; 47(4):351-361. PubMed ID: 33086403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19.
    Braude P; Carter B; Short R; Vilches-Moraga A; Verduri A; Pearce L; Price A; Quinn TJ; Stechman M; Collins J; Bruce E; Einarsson A; Rickard F; Mitchell E; Holloway M; Hesford J; Barlow-Pay F; Clini E; Myint PK; Moug S; McCarthy K; Hewitt J
    Int J Cardiol Heart Vasc; 2020 Dec; 31():100660. PubMed ID: 33083516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Prior Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Treatment on Coronavirus Disease 2019 (COVID-19) Susceptibility and Outcome: A Systematic Review and Meta-analysis.
    Xu J; Teng Y; Shang L; Gu X; Fan G; Chen Y; Tian R; Zhang S; Cao B
    Clin Infect Dis; 2021 Jun; 72(11):e901-e913. PubMed ID: 33079200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden.
    Rudberg AS; Havervall S; Månberg A; Jernbom Falk A; Aguilera K; Ng H; Gabrielsson L; Salomonsson AC; Hanke L; Murrell B; McInerney G; Olofsson J; Andersson E; Hellström C; Bayati S; Bergström S; Pin E; Sjöberg R; Tegel H; Hedhammar M; Phillipson M; Nilsson P; Hober S; Thålin C
    Nat Commun; 2020 Oct; 11(1):5064. PubMed ID: 33033249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    RECOVERY Collaborative Group
    Lancet; 2020 Oct; 396(10259):1345-1352. PubMed ID: 33031764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
    ; Horby P; Mafham M; Linsell L; Bell JL; Staplin N; Emberson JR; Wiselka M; Ustianowski A; Elmahi E; Prudon B; Whitehouse T; Felton T; Williams J; Faccenda J; Underwood J; Baillie JK; Chappell LC; Faust SN; Jaki T; Jeffery K; Lim WS; Montgomery A; Rowan K; Tarning J; Watson JA; White NJ; Juszczak E; Haynes R; Landray MJ
    N Engl J Med; 2020 Nov; 383(21):2030-2040. PubMed ID: 33031652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019.
    Burwick RM; Yawetz S; Stephenson KE; Collier AY; Sen P; Blackburn BG; Kojic EM; Hirshberg A; Suarez JF; Sobieszczyk ME; Marks KM; Mazur S; Big C; Manuel O; Morlin G; Rose SJ; Naqvi M; Goldfarb IT; DeZure A; Telep L; Tan SK; Zhao Y; Hahambis T; Hindman J; Chokkalingam AP; Carter C; Das M; Osinusi AO; Brainard DM; Varughese TA; Kovalenko O; Sims MD; Desai S; Swamy G; Sheffield JS; Zash R; Short WR
    Clin Infect Dis; 2021 Dec; 73(11):e3996-e4004. PubMed ID: 33031500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of DPP-4 inhibitor in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis.
    Liu Y; Xie H; Gao H; Xie C
    Medicine (Baltimore); 2020 Oct; 99(41):e22592. PubMed ID: 33031311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update Alert 5: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.
    Mackey K; Kansagara D; Vela K
    Ann Intern Med; 2020 Dec; 173(12):167-168. PubMed ID: 33105094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.